|
Predictors of Hemoglobin Response to Eculizumab Therapy in Paroxysmal Nocturnal Hemoglobinuria
|
Oct 2012
|
Eur J Haematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Pretransplantation Therapy with Hypomethylating Agents in Patients with Myelodysplastic Syndromes Receiving Reduced-Intensity Conditioning Regimens
|
Jul 2014
|
Biol Blood Marrow Transplant
|
myelodysplastic syndromes (MDS)
|
|
Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA As compared with BM
|
Aug 2017
|
Leukemia
|
aplastic anemia
|
|
Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents
|
Dec 2015
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes
|
Oct 2014
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients
|
Nov 2015
|
Mayo Clin Proc
|
myelodysplastic syndromes (MDS)
|
|
Pro-inflammatory proteins S100A9 and TNFα suppress erythropoietin elaboration in myelodysplastic syndromes
|
Oct 2017
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Prognostic factors and risk models in myelodysplastic syndromes
|
Sep 2013
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine.
|
Dec 2012
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
